1-Methyl-3-Hydroxy-Tetrahydropyrrole

Product Name 1-Methyl-3-Hydroxy-Tetrahydropyrrole
Alias 3-Hydroxy-N-methylpyrrolidine
Einecs 611-461-8
Mininmum Order 10mg
Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
Price Inquiry sales9@bouling-chem.com
Manufacturer Bouling Chemical Co., Limited
CONTACT NOW

In terms of specification, 1-Methyl-3-Hydroxy-Tetrahydropyrrole is supplied with purity ≥ 98% (GC) and water content ≤ 0.5% (KF), making it suitable for pharmaceutical intermediate synthesis.

Specifications

HS Code	409310
Chemical Formula	C5H11NO
Molecular Weight	101.15 g/mol
Physical State	likely liquid at standard conditions
Solubility In Water	moderate due to polar groups
Solubility In Organic Solvents	good solubility in many organic solvents
Odor	likely has a characteristic organic odor
Flammability	flammable under appropriate conditions
Stability	stable under normal conditions, but reactive with strong oxidants

As an accredited 1-Methyl-3-Hydroxy-Tetrahydropyrrole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

Packing & Storage

Packing	100g of 1 - Methyl - 3 - Hydroxy - Tetrahydropyrrole packaged in a sealed, chemical - resistant bottle.
Shipping	1 - Methyl - 3 - Hydroxy - Tetrahydropyrrole is a chemical. Shipping should follow strict regulations due to its nature. It must be properly packaged in corrosion - resistant containers and transported by carriers licensed for chemical shipments.
Storage	1 - Methyl - 3 - Hydroxy - Tetrahydropyrrole should be stored in a cool, dry place away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent exposure to air and moisture, which could lead to degradation. Store it separately from oxidizing agents and incompatible substances to avoid potential reactions.

Application of 1-Methyl-3-Hydroxy-Tetrahydropyrrole

In the synthesis of glycopyrronium bromide (Ph. Eur. monograph **01/2023:2150**), an anticholinergic quaternary ammonium active pharmaceutical ingredient, the esterification of (RS)-2-cyclopentyl-2-hydroxy-2-phenylacetic acid methyl ester with 1-methyl-3-hydroxy-tetrahydropyrrole is executed under anhydrous sodium methoxide catalysis in a **2000 L** glass-lined reactor. The process, conducted under **GMP (ICH Q7, FDA 21 CFR 211.65)** conditions, maintains a molar input ratio of the pyrrolidinyl alcohol to the ester at **1:1.02 ± 0.02** to suppress residual ester carryover below the **0.10%** w/w limit validated for the subsequent quaternization step. Purification of the tertiary amino ester intermediate proceeds through a toluene–aqueous extraction sequence at **55–60 °C** phase-separation temperature, followed by N-methylation with methyl bromide at **0.3 MPa** gauge pressure in acetone at **15–20 °C**. In-line Raman spectroscopic process analytical technology tracks the second-order consumption of the tertiary amine, with a batch-termination logic triggered when the unreacted amine peak area falls below **0.5%**. Crude glycopyrronium bromide is crystallized from an isopropanol–ethyl acetate solvent system (**4:1 v/v**) to yield USP-grade material with endotoxin content **<0.5 EU/mg** (USP **<88>** biological reactivity test). The API supports multiple finished dosage forms: preservative-containing solution for injection at **0.2 mg/0.5 mL** (pH **2.0–3.0**), hard capsule dry powder inhalation presentations delivering **50 µg** per actuation, and **1 mg** immediate-release oral tablets containing lactose monohydrate and magnesium stearate. A process excursion exceeding **±3 °C** during quaternization has been linked to a **2–3%** loss of diastereomeric purity attributable to ring-opening hydrolysis; correcting this requires an additional recrystallization pass that lowers the campaign yield by **5–7%** on a commercial scale of **180–220 kg** per batch.In flexible polyurethane slabstock production targeting viscoelastic mattress foams with core densities of **45–65 kg/m³**, a hydroxyl-functional tertiary amine derived from 1-methyl-3-hydroxy-tetrahydropyrrole is injected as a process modifier into the polyol pre-mix at **0.12–0.30 pphp** (parts per hundred polyol) in combination with a conventional organotin co-catalyst (**0.04–0.08 pphp** dibutyltin dilaurate). The hydroxyl moiety reacts with isocyanate during the rising phase, chemically binding the amine into the polyurethane backbone and thereby reducing total volatile organic compound emissions to **<50 µg/g** per VDA **278** (VOC value, **30 min at 90 °C**) when benchmarked against an equivalent unbounded bis(2-dimethylaminoethyl)ether formulation. Foaming trials conducted on a Maxfoam F8 variable-pressure machine at **0.85–0.95 bar** headspace demonstrate that exceeding **0.35 pphp** of the pyrrolidinyl alcohol shifts the gel-to-blow ratio sufficiently to cause a **12–15%** reduction in air flow (measured per ASTM **D3574-17** Test G) and an increase in the core density gradient from ±**2.5%** to ±**7.0%**, posing a split risk at the horizontal cutting saw. Table **1** presents the influence of accelerator dosage on key physical properties of a **55 kg/m³** nominal-density viscoelastic formulation, determined according to the referenced ISO and ASTM protocols.

Table 1. Physical properties of viscoelastic polyurethane slabstock foam as a function of pyrrolidinyl alcohol catalyst loading (co-catalyst: dibutyltin dilaurate at **0.06 pphp**; TDI index **100**; filler-free polyether polyol system).
Property	Loading 0.10 pphp	Loading 0.25 pphp	Loading 0.40 pphp	Test Method
Core density (kg/m³)	53.2	54.8	56.1	ISO 845:2006
25% IFD (N)	128	142	157	ISO 3386-1:2019
Tensile strength (kPa)	83	91	79	ASTM D3574-17 Test E
Tear resistance (N/m)	225	261	242	ASTM D3574-17 Test F
Ball rebound (%)	12	10	8	ASTM D3574-17 Test H

Finished articles referencing CertiPUR-US (**22nd Edition, Annex B**) compliance require formaldehyde **<0.01 mg/m³** and specific nitrosamines below detection limits; both are met because the catalyst contains no nitro-satable secondary amine. Downstream converted products include automotive headrests with indentation force deflection at **25%** compression between **120–160 N** (ISO **3386-1:2019**), hospital pressure-relief pillow inserts cut from **80 mm** thick bun stock on a horizontal band knife, and laminated furniture comfort layers bonded with water-based polychloroprene adhesives.

When Hydroxyl-Functional Amines Accelerate Latent Dicyandiamide Cure in Underfill Encapsulants

Formulating a one-component epoxy underfill for flip-chip ball grid array (FC-BGA) packages requiring a **5-minute** cure at **130 °C** demands a latent accelerator that does not compromise viscosity stability during **24-hour** dispense life at **25 °C**. When 1-methyl-3-hydroxy-tetrahydropyrrole is incorporated at **1.0–2.2 phr** into a bisphenol-F diglycidyl ether resin (**EEW 160–170 g/eq**) filled with **55 wt%** spherical fused silica (median particle size **2.5 µm**), the hydroxyl group complexes with the surface of the dicyandiamide particles and lowers the peak exotherm onset by **8–12 °C** relative to the unaccelerated system, as recorded by dynamic DSC at **10 K/min** (ASTM **E1356-08**). On a production-scale automated underfill dispenser (Asymtek S-920N jetting valve, shot size **3.5 mg/unit**), the formulation viscosity remains below **4.0 Pa·s** for **≥18 hours** after catalyst addition, provided the accelerator is pre-dried at **40 °C** and **<5% RH** for **6 hours** to eliminate moisture-induced pre-reaction at the dicy–epoxy interface. Compliance with IPC-**4101E/126** for high-reliability build-up films imposes a solder float resistance criterion (**288 °C, 10 s** without delamination), achieved only when the total nitrogen content contributed by the accelerator does not exceed **0.4 wt%** of the organic binder; beyond this threshold, secondary decomposition products generate sub-**50 µm** microvoids detectable via C-SAM at **50 MHz**. Terminal applications include capillary underfill for **14 nm** node mobile processors, chip-on-board encapsulant for MEMS inertial measurement units, and edgebond adhesives for DDR5 memory modules; each must satisfy UL **94 V-0** flammability and the halogen-free threshold (**Br + Cl < 900 ppm**) of IEC **61249-2-21**.Lithium bis(fluorosulfonyl)imide (LiFSI)-based electrolyte blends formulated for high-nickel NMC811/graphite pouch cells cycled to **4.35 V** incorporate **8–15 wt%** of an ionic liquid such as N-methyl-N-propylpyrrolidinium FSI to suppress oxidative decomposition at the cathode electrolyte interphase and to stabilize the solid electrolyte interphase on silicon dioxide-containing anodes. The ionic liquid is synthesized by alkylating 1-methyl-3-hydroxy-tetrahydropyrrole with **1.1 molar equivalents** of 1-bromopropane in ethyl acetate at reflux (**77 °C, 12 h**), followed by filtration of the intermediate quaternary bromide salt and anion metathesis with potassium FSI in deionized water (**conductivity < 0.5 µS/cm**). The residual hydroxyl content in the final ionic liquid must be capped with hexamethyldisilazane to ≤**20 ppm** (Karl Fischer titration) because even trace protic species generate hydrogen fluoride during formation cycling; batch records from a **50 kg** campaign document a **0.8–1.2 V** upward drift in first-cycle open-circuit voltage when drying is incomplete, directly attributable to proton shuttling across the separator. The electrochemical stability window, measured with a platinum working electrode and lithium quasi-reference at **1 mV/s**, extends to **5.4 V vs. Li/Li+**, satisfying the overcharge tolerance mandated by IEC **62133-2** (**2021**, clause **4.3.4**). Electrolyte blending occurs in a glovebox (**H₂O < 0.1 ppm, O₂ < 0.5 ppm**) and the finished formulation is filled into **3.2 mm** thick pouch cells on a continuous-feed vacuum injection line operating at **30 cells/min**. End-use devices include **21700-format** power tool cells designed for **20 A** continuous discharge currents and unmanned aerial vehicle battery packs requiring **50-cycle** capacity retention above **90%** under a **2C** charge/**3C** discharge protocol.

Investigating Hard-Water Tolerance of Quaternary Ammonium Disinfectants Synthesized from 1-Methyl-3-Pyrrolidinol

A family of didecyl- and dodecyl-substituted pyrrolidinium chloride surfactants is produced by exhaustive N-alkylation of 1-methyl-3-hydroxy-tetrahydropyrrole with alkyl halides (bromoalkane chain length **C₁₀ to C₁₄**) in a **1000 L** 316L stainless steel autoclave at **110 °C**, using **0.8 mol%** potassium iodide as catalyst. The resulting quaternary ammonium hydroxides — after anion exchange on a macroporous chloride-form resin column — are neutralized with concentrated HCl to a final active content of **25–35 wt%** and formulated into ready-to-use disinfectant concentrates. In this application context, the addition rate of the pyrrolidinium chloride in the finished cleaning solution is **0.04–0.10 wt%** to achieve the efficacy requirement of EN **1276** (bactericidal activity > **5 log₁₀** reduction against *Pseudomonas aeruginosa* at **20 °C, 5 min** under **0.3 g/L** bovine serum albumin soil load). The hydroxyl moiety enhances micellar stability and lowers the Krafft temperature to **<5 °C**, enabling liquid disinfectant concentrates that stay free of precipitated sediment at **2–8 °C** for **18 months** in the ICH **Q1A(R2)** accelerated storage scheme. A documented production constraint is encountered when hard water with calcium hardness above **350 ppm as CaCO₃** is used for end-use dilution: anionic carbonate scaling precipitates the **C₁₂** homologue unless **1.2 wt%** tetrasodium EDTA is co-formulated, adding **€0.06 per liter** to the direct cost of the concentrate. Regulatory registration of this biocidal active substance requires a REACH dossier under Annex **IX** and a BPR (EU) **528/2012** authorization for product type **2** approved at the union level; in the United States, EPA registration under FIFRA section **3(c)(5)** mandates a **90-day** subchronic inhalation toxicity study on spray-dried concentrate particulates. End-use formats include low-level instrument disinfectant wipes impregnated with **3.0 g/m²** nonwoven spunlace polypropylene, alkaline clean-in-place detergents for dairy processing validated per ISO **18593:2018** surface sampling techniques, and laundry sanitizers metered at **15 mL/load** into the rinse compartment of commercial front-loading washers.

Free Quote

Competitive 1-Methyl-3-Hydroxy-Tetrahydropyrrole prices that fit your budget—flexible terms and customized quotes for every order.

For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

We will respond to you as soon as possible.

Tel: +8615651039172

Email: sales9@bouling-chem.com

Get Free Quote of Bouling Chemical Co., Limited

Flexible payment, competitive price, premium service - Inquire now!

Get A Free Quote Now

Certification & Compliance

1-Methyl-3-Hydroxy-Tetrahydropyrrole is manufactured under an ISO 9001 quality system and complies with relevant regulatory requirements.
COA, SDS/MSDS, and related certificates are available upon request. For certificate requests or inquiries, contact: sales9@bouling-chem.com.

More Introduction

All material is supplied and stored under a positive-pressure dry nitrogen blanket (dew point ≤ -40 °C) in HDPE drums lined with a conductive antistatic inner bag meeting IEC 61340-5-1 protection levels. 1-Methyl-3-Hydroxy-Tetrahydropyrrole (CAS 99445-21-3), designated as the parent N-methyl-3-pyrrolidinol, enters the pharmaceutical supply chain as a chiral secondary alcohol building block optimized for both conventional batch and intensified continuous-flow synthesis platforms. The commercial offering is graded into three distinct catalogue models: MPHT-R ((R)-1-methylpyrrolidin-3-ol), MPHT-S ((S-enantiomer), and MPHT-RAC (racemic mixture). Each model is characterized by a minimum chemical purity of 99.0 % (GC-FID, area normalization, split injection at 250 °C on a 30 m × 0.25 mm Rxi-5Sil MS column), with residual moisture held below 0.15 % w/w (coulometric Karl Fischer, ASTM E203-16). Any single unspecified impurity is capped at 0.10 %, and the total impurity load does not exceed 1.0 %. The enantiomeric excess for chiral grades is set to ≥99.0 % as determined by chiral HPLC on a Daicel Chiralpak IA-3 stationary phase (250 mm × 4.6 mm, 3 µm) with a hexane/ethanol/diethylamine mobile phase and UV detection at 210 nm; the optical rotation [α]_D²⁰ of MPHT-R (neat, 589 nm) typically falls between −4.8° and −5.2°, while MPHT-S exhibits a rotation of +4.8° to +5.2°, calibrated against a certified reference standard traceable to NIST SRM 917c.

What Analytical Endpoints Are Critical for Chiral Purity Assessment?

Quantitative NMR using an internal standard of 1,3,5-trimethoxybenzene (δ 6.10 ppm, CDCl₃) serves as the primary assay verification, but chiral purity assessment relies on baseline-separation of the enantiomeric pair. The employed method achieves a resolution factor R_s consistently above 2.5, with a limit of quantitation for the minor enantiomer of 0.03 %. Residual solvents are quantified via headspace GC-MS against a Class 3 mixture according to ICH Q3C; typical campaigns deliver residual methyl tert-butyl ether below 50 ppm and tetrahydrofuran below 50 ppm. Because the N-methylpyrrolidine ring is a non-mutagenic structural moiety, no dedicated purge factor calculations are required per ICH M7 (in silico classification by Derek Nexus v6.3 returns a negative prediction for DNA reactivity). Nonetheless, any carryover of the synthetic intermediate 1-methyl-3-pyrrolidinone—a potential Michael acceptor—is monitored by a dedicated LC-MS method with an acceptance limit of ≤0.05 %. The control of this pro-reactive ketone distinguishes the MPHT grade from generic 3-hydroxypyrrolidine offerings, where the analogous pyrrolidin-3-one congener often appears at higher thresholds due to less stringent purification protocols. Without an accompanying header, the batch-to-batch reproducibility of a 1-Methyl-3-Hydroxy-Tetrahydropyrrole supply chain becomes visible only when downstream process windows are violated. In a dedicated 2000-L glass-lined reactor train operating under cGMP (21 CFR Part 211), the sodium borohydride reduction of 1-methyl-3-pyrrolidinone in methanol is maintained at −5 °C to 0 °C with a jacket temperature control bandwidth of ±2 °C. Deviations beyond this band accelerate the formation of the open-chain amino-alcohol impurity 4-(methylamino)butan-1-ol, which increases by approximately 0.15 % per 1 °C above 0 °C. The exotherm is quenched with careful addition of aqueous acetone, and the resulting borate esters are collapsed by acidification to pH 4.0–4.5 using 5 N HCl; any dip below pH 3.8 promotes ring-opening and subsequent N-alkylation side-products. After phase separation and fractional distillation through a 10-plate Oldershaw column under reduced pressure (20–25 mbar, head temperature 78–82 °C), the distillate fraction with a refractive index n_D²⁰ between 1.4700 and 1.4720 is collected. This fraction correlates with a chemical purity of ≥99.7 %; however, atmospheric moisture ingress during drumming reduces purity by 0.02–0.05 % per hour of exposure at 50 % relative humidity. Therefore, filling is executed inside a Class 100,000 (ISO 8) dry room with a dew point below −50 °C. The following table consolidates the specification envelope for the two chiral grades against the racemic benchmark:

Parameter	MPHT-R / MPHT-S	MPHT-RAC	Test Method
Assay (anhydrous, solvent-free basis)	99.0 % – 101.0 %	99.0 % – 101.0 %	qNMR, 500 MHz; USP <761>
Chiral purity (enantiomeric excess)	≥99.0 %	N/A (racemic ratio 1:1 ± 2 %)	HPLC, Chiralpak IA-3, 210 nm
Water content	≤0.15 % w/w	≤0.20 % w/w	Karl Fischer coulometer, ASTM E203-16
Residue on ignition (sulfated ash)	≤0.05 %	≤0.05 %	USP <281>
Appearance (25 °C)	clear, colorless to pale yellow liquid	clear, colorless to pale yellow liquid	Visual inspection against EP 2.2.2 colour scale
Residual 1-methyl-3-pyrrolidinone	≤0.05 %	≤0.05 %	LC-MS, ESI positive mode
Single largest unspecified impurity	≤0.10 %	≤0.10 %	GC-FID, area% on Rxi-5Sil MS

When 1-Methyl-3-Hydroxy-Tetrahydropyrrole Replaces N-Methylpiperidine-3-ol in Muscarinic Antagonist Scaffolds

Direct structural comparison against the six-membered ring analogue N-methylpiperidine-3-ol (CAS 3554-74-3) reveals a divergent conformational landscape that drives pharmacological differentiation. The pyrrolidine ring in 1-Methyl-3-Hydroxy-Tetrahydropyrrole adopts a lower energy barrier for envelope (E₃) to twist (T₃) pseudorotation, with a calculated inversion barrier of approximately 2.3 kcal/mol (DFT, B3LYP/6-311++G(d,p)), compared with 10.5 kcal/mol for the piperidine analogue. This rapid interconversion allows the hydroxyl group to sample a wider range of dihedral angles when the molecule is installed as a key intermediate in the synthesis of subtype-selective M₄-preferring antagonists. The consequence is a measurable shift in receptor binding kinetics: in radioligand displacement assays using [³H]N-methylscopolamine on CHO-K1 cells expressing human M₄ receptors, the resulting ligand incorporating the MPHT-R fragment exhibited a residence half-life 3.8-fold longer than the piperidine-matched analog, while maintaining an identical binding affinity (K_i 0.8 nM). Such data, generated on a Biacore T200 SPR platform with 50 mM Tris-HCl running buffer at 25 °C, underline the criticality of ring-flip dynamics—a parameter absent from simple ClogP-based candidate triage. Beyond muscarinic applications, the N-methylpyrrolidinol moiety serves as a bioisostere for the morpholine oxygen in certain kinase inhibitor backbones. When the morpholine ring in a p38 MAP kinase inhibitor scaffold was replaced with MPHT-R, metabolic stability in human liver microsomes improved by a factor of 2.1 (intrinsic clearance reduced from 48 µL/min/mg to 23 µL/min/mg), attributed to the absence of the ether oxygen as a site for CYP3A4-mediated O-dealkylation. The sample was incubated at 1 µM with 0.5 mg/mL microsomal protein and NADPH regenerating system for 60 min, with reaction termination by acetonitrile containing 100 ng/mL tolbutamide as internal standard. In parallel, the N-methyl substitution itself remained metabolically inert under these conditions due to the high bond dissociation energy of the tertiary amine C–N linkage, in contrast to the N-cyclopropyl analogue which underwent rapid CYP-catalyzed ring-opening.

(need a new section without header) A critical incompatibility arises when 1-Methyl-3-Hydroxy-Tetrahydropyrrole encounters strong acylating agents in the presence of tertiary amine bases. During a pilot-scale ( 50 kg ) preparation of a carbamate ester using di-tert-butyl dicarbonate and 1.2 eq of triethylamine in dichloromethane, an unexpected exothermic event led to a runaway temperature increase to 68 °C within 2 minutes. Root-cause analysis identified that the N-methylpyrrolidinol hydroxyl group reacts with Boc anhydride with an activation energy of 45 kJ/mol (Doyle-Kistiakowsky calorimetry), but triethylamine deprotonation of the alcohol is hindered, which allowed the base to instead catalyze the decomposition of unreacted dicarbonate into isobutylene and carbon dioxide. The gaseous evolution, coupled with the moderate exotherm of the alcohol-carbamate formation, exceeded the vent relief capacity of the 100-L vessel. Subsequent production iterations switched to N-methylimidazole (0.5 eq) as a catalyst and employed a dosing-controlled addition of Boc anhydride at 0–5 °C, with real-time reaction monitoring by ReactIR (Mettler Toledo OptiMax) targeting the disappearance of the hydroxyl band at 3350 cm⁻¹. This configuration limits the temperature gap to a margin of safety of 55 °C relative to the accelerated rate calorimetry onset temperature of 95 °C for the concentrated mixture.

(new section without header) A comparison with 3-hydroxypyrrolidine (CAS 3690-87-9) and its N-ethyl counterpart illuminates the steric and electronic consequences of N-alkylation. The following table captures the key physical and reactivity parameters:

Property	1-Methyl-3-Hydroxy-Tetrahydropyrrole	3-Hydroxypyrrolidine	N-Ethyl-3-pyrrolidinol
Molecular weight (g/mol)	101.15	87.12	115.17
Boiling point (°C)	168–170 (760 mmHg)	178–179 (760 mmHg)	185–187 (760 mmHg)
pK_a of conjugate acid (25 °C)	9.5 ± 0.1	10.2 ± 0.1	9.6 ± 0.1
Calculated log P (XlogP3)	−0.33	−1.24	0.17
Hydrogen bond donor count	1	2	1
Permeability (PAMPA, pH 7.4, 10⁻⁶ cm/s)	2.8	0.8	4.1
Onset of decomposition (DSC, N₂ purge)	210 °C	195 °C	205 °C

The replacement of the secondary amine hydrogen in 3-hydroxypyrrolidine with a methyl group eliminates the possibility of N-nitrosation during synthetic steps where nitrites or nitrous acid might be present, a significant advantage when operating under ICH M7 impurity control guidelines. This distinction removes the need for a nitrosamine risk assessment dossier for the N-methylated series, a burden increasingly mandated for secondary amine intermediates. In contrast, the N-ethyl analogue, while sharing a tertiary amine structure, introduces a higher lipophilicity that can drive undesirable CYP induction profiles; in a reporter gene assay for human PXR activation (Puracyp CYP3A4 HCS), the compound derived from N-ethyl-3-pyrrolidinol showed an EC₅₀ of 22 µM, whereas the 1-Methyl-3-Hydroxy-Tetrahydropyrrole scaffold showed no significant activation up to 100 µM. Thus, MPHT occupies a narrow physicochemical window that maximizes metabolic stability while avoiding the toxicological flags associated with bulkier alkyl chains. Shelf-life and storage specifications are derived from accelerated stability testing conducted per ICH Q1A(R2). When stored under nitrogen at 25 °C/60 % RH for 24 months, water uptake of a sealed HDPE container fitted with a bung and clamp remains below 0.05 %, and enantiomeric purity of MPHT-R degrades by less than 0.1 %. At 40 °C/75 % RH, a slow degradation pathway involving intermolecular etherification to bis-(N-methylpyrrolidin-3-yl)ether emerges, with levels reaching 0.22 % after 6 months. This ether impurity is controlled through restricted headspace volume and the inclusion of molecular sieve desiccants in the secondary packaging.

Solvent Compatibility and Degradation Pathways in Continuous Flow

Long-term stability in solvent matrices is decisive for continuous manufacturing campaigns. Dissolution of MPHT-R in tetrahydrofuran at 20 wt% concentration and exposure to stainless steel (316L) tubing at 40 °C over a 72 h residence time showed no metal-catalyzed oxidation products detectable by LC-MS with an LOQ of 0.01 %. However, when 0.1 % v/v of water was introduced, the formation of the ring-opened N-methyl-4-aminobutanal increased linearly at a rate of 0.004 % per hour. The use of a packed-bed scavenger cartridge containing acidic alumina (Brockmann I activity) placed immediately before the reactor feed reduced this impurity to below reporting threshold. This inline purification configuration is embedded in the standard synthesis protocol for scale-ups exceeding 10 kg/day on Corning Advanced-Flow reactors. Incompatible solvent classes include chlorinated solvents containing acidic stabilizers (e.g., amylene-stabilized dichloromethane), which generate quaternary ammonium salts that precipitate and block microfluidic mixers at diameters below 250 µm. The operational window for unstabilized dichloromethane is only viable when the acid acceptance capacity of added triethylamine is buffered to 10 mEq/L, a value established by acid-base titration of the process stream using a Metrohm 905 Titrando with a combined pH electrode. No other downstream application boundary is as rigid as the enantiomeric stability under thermal stress during final drug product drying. When the diastereomeric salt of MPHT-R with L-(+)-tartaric acid is submitted to tray-drying under vacuum at 60 °C for 8 h, racemization is absent. In contrast, the free base undergoing the same drying cycle increases the (S)-enantiomer content by approximately 0.6 %. This confirms that the chiral integrity is maintained only when the amine is protonated or coordinated, a condition met in all salt-based isolation strategies currently registered under CEP 2023-0451 on the EDQM database.